Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Window of opportunity: Estrogen as a treatment for ischemic stroke
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Window of opportunity: Estrogen as a treatment for ischemic stroke'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Estrogen
100%
Clinical Trials
100%
Ischemic Stroke
100%
Window of Opportunity
100%
Estrogen Replacement Therapy
80%
Experimental Stroke
40%
Acute Treatment
40%
Estrogen Treatment
40%
Stroke Research
40%
Recombinant Tissue Plasminogen Activator (rt-PA)
40%
Protective Effect
20%
Neuroprotection
20%
Protective Behavior
20%
Neurodegenerative Diseases
20%
Adverse Effects
20%
In Vivo Model
20%
Postmenopausal Women
20%
Stroke Prevention
20%
Clinical Conditions
20%
Experimental Ischemic Stroke
20%
Potential Interaction
20%
Hormone Therapy
20%
Neuroprotectant
20%
Neurovascular Unit
20%
Primary Stroke Prevention
20%
Mistranslation
20%
Secondary Stroke Prevention
20%
Combined Therapy
20%
Neuroprotective Action
20%
Research Trials
20%
Treatment Paradigms
20%
Ischemic Stroke Models
20%
Neuroscience
Brain Ischemia
100%
Estrogen
100%
Cerebrovascular Accident
85%
Estrogen Replacement Therapy
57%
Alteplase
28%
In Vivo
14%
In Vitro
14%
Neuroprotection
14%
Neuroprotective Agent
14%
Neurodegenerative Disorder
14%
Adverse Effect
14%
Hormone Therapy
14%
Biological Marker
14%
Critical Period
14%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
100%
Estrogen
100%
Clinical Trial
45%
Replacement Therapy
36%
Cerebrovascular Accident
36%
Alteplase
18%
Experimental Stroke
18%
Neuroprotection
9%
Neuroprotective Agent
9%
Biological Marker
9%
Adverse Event
9%
Degenerative Disease
9%
Endocrine Therapy
9%
Psychology
Clinical Trial
100%
Critical Period
20%
Economic and Social Development
20%